Author Question: What are the potential beneficial effects of taking vitamin E (alpha-tocopherol) supplements? ... (Read 76 times)

captainjonesify · **on:** Jul 23, 2018

What are the potential beneficial effects of taking vitamin E (alpha-tocopherol) supplements? (Select all that apply.)

a. Delayed progression of macular degenera-tion
b. Improved blood clotting
c. Lowered risk of developing Alzheimer's disease
d. Reduced risk of cardiovascular disease
e. Reduced risk of colds in elderly patients

Question 2

A patient receiving menotropins Repronex for infertility comes to the clinic for evaluation on the ninth day of treatment. Her serum estrogen level is 200 pg/mL per maturing follicle. An ul-trasound reveals that follicles have enlarged to 22 mm.

The patient complains of left lower ab-dominal pain. What will the nurse do? a. Administer human chorionic gonadotro-pin, because the ovary has ripened.
b. Assess for abdominal fullness and disten-sion and auscultate lung sounds.
c. Inform the patient that the pain is asso-ciated with ovulation.
d. Recommend ibuprofen for pain and admi-nister the next dose of menotropins.

emily12345 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A, E
Studies to determine the potential benefits of vitamin E supplements show a decreased risk of colds in elderly patients when vitamin E is combined with vitamin C, beta-carotene, zinc, and copper, and a potential delay in the progression of macular degeneration. Vitamin E may actually increase the risk of bleeding. Studies have not shown a decrease in the risk of Alzheimer's dis-ease or cardiovascular disease.

Answer to Question 2

B
Menotropins can cause ovarian hyperstimulation syndrome, which can cause sudden enlargement of the ovaries. When it occurs rapidly and is accompanied by ascites, pleural effusion, and pain, the patient should be hospitalized and the menotropins should be withdrawn. Although the follicular size and estrogen level indicate a ripened ovary, the first priority is to assess for ovarian hyperstimulation syndrome, because this patient reports pain. Ovulation will not occur until hCG is given, so this pain is not associated with ovulation. Until ovarian hyperstimulation syndrome has been ruled out, it is not appropriate to administer the next dose of menotropins.